BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9586892)

  • 21. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party.
    Lancet; 1996 Dec; 348(9042):1610-4. PubMed ID: 8961990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.
    Inoue M; Ohta M; Iuchi K; Matsumura A; Ideguchi K; Yasumitsu T; Nakagawa K; Fukuhara K; Maeda H; Takeda S; Minami M; Ohno Y; Matsuda H;
    Ann Thorac Surg; 2004 Jul; 78(1):238-44. PubMed ID: 15223436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
    Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N
    Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
    Kato T; Ohashi Y; Nakazato H; Koike A; Saji S; Suzuki H; Takagi H; Nimura Y; Hasumi A; Baba S; Manabe T; Maruta M; Miura K; Yamaguchi A
    Langenbecks Arch Surg; 2002 Mar; 386(8):575-81. PubMed ID: 11914933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant and palliative immunotherapy of colorectal carcinoma].
    Schlimok G
    Praxis (Bern 1994); 1997 Sep; 86(39):1517-9. PubMed ID: 9411672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Successful use of adjuvant immunotherapy in resected colorectal tumors].
    Würschmidt F; Baumann M
    Strahlenther Onkol; 1995 Mar; 171(3):175-6. PubMed ID: 7709334
    [No Abstract]   [Full Text] [Related]  

  • 31. Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer.
    Katoh H; Yamashita K; Kokuba Y; Satoh T; Ozawa H; Hatate K; Ihara A; Nakamura T; Onozato W; Watanabe M
    Anticancer Res; 2008; 28(3B):1933-41. PubMed ID: 18630484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
    Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
    Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features of serrated adenocarcinoma defined by Mäkinen in dukes' B colorectal carcinoma.
    Shida Y; Fujimori T; Tanaka H; Fujimori Y; Kimura R; Ueda H; Ichikawa K; Tomita S; Nagata H; Kubota K; Tsubaki M; Kato H; Yao T; Sugai T; Sugihara K; Ohkura Y; Imura J
    Pathobiology; 2012; 79(4):169-74. PubMed ID: 22433973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
    Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
    Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.